Literature DB >> 27320130

Respiratory infections and gastrointestinal illness on a cruise ship: A three-year prospective study.

Androula Pavli1, Helena C Maltezou2, Antonis Papadakis3, Panagiotis Katerelos2, Georgios Saroglou4, Athanasios Tsakris5, Sotirios Tsiodras6.   

Abstract

BACKGROUND: Cruise ships carry a large number of people in confined spaces providing an environment for transmission of infections. The aim of this study is to estimate the incidence of and describe the spectrum of respiratory infections and gastrointestinal illness among passengers and crew of cruise Ship A.
MATERIAL AND METHODS: The study was carried out from January 2011 to December 2013 on cruise Ship A, including passengers and crew who presented with symptoms suggestive of acute respiratory infection (ARI), influenza-like illness (ILI) and gastrointestinal illness (GI). Advice about preventive measures of respiratory and gastrointestinal infections and influenza vaccination was given to passengers and crew. Data were collected by using one standardized form per patient.
RESULTS: The most common destination was Northern Europe (90.7%). The mean duration of cruise was 10.6 days; 440 passengers and 421 crew members who sought medical attention were studied (mean age 72.6 ± 9.5 and 33 ± 7 years, respectively). ILI, ARI and GI were diagnosed in 32.7%, 15.9%, 17% and 10.9%, 80%, 0.2% of ill passengers and crew, respectively. The association of ARI, ILI and GI incidence in passengers was statistically significant with season, destination and duration of travel; the incidence for all illnesses was higher during winter, for travel to South America and for >14 days (p-value<0.001).
CONCLUSION: ARI, ILI and GI continue to pose a burden on cruise travel; therefore pre-travel advice is crucial for passengers and crew regarding respiratory and gastrointestinal infections. Surveillance and implementation of control measures are important for outbreak prevention.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute respiratory infection; Crew; Cruise; Influenza-like illness; Passengers

Mesh:

Year:  2016        PMID: 27320130     DOI: 10.1016/j.tmaid.2016.05.019

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  5 in total

1.  COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures.

Authors:  J Rocklöv; H Sjödin; A Wilder-Smith
Journal:  J Travel Med       Date:  2020-05-18       Impact factor: 8.490

2.  Maritime illness and death reporting and public health response, United States, 2010-2014.

Authors:  Caroline E Stamatakis; Marion E Rice; Faith M Washburn; Kristopher J Krohn; Millicent Bannerman; Joanna J Regan
Journal:  Travel Med Infect Dis       Date:  2017-10-14       Impact factor: 6.211

3.  Dynamic network strategies for SARS-CoV-2 control on a cruise ship.

Authors:  Samuel M Jenness; Kathryn S Willebrand; Amyn A Malik; Benjamin A Lopman; Saad B Omer
Journal:  Epidemics       Date:  2021-08-18       Impact factor: 5.324

Review 4.  A review of COVID-19 transmission dynamics and clinical outcomes on cruise ships worldwide, January to October 2020.

Authors:  Kathryn S Willebrand; Lauren Pischel; Amyn A Malik; Samuel M Jenness; Saad B Omer
Journal:  Euro Surveill       Date:  2022-01

5.  Impact of Doxycycline as Malaria Prophylaxis on Risk of Influenza-Like Illness among International Travelers.

Authors:  Kathryn Lago; Kalyani Telu; David Tribble; Anuradha Ganesan; Anjali Kunz; Charla Geist; Jamie Fraser; Indrani Mitra; Tahaniyat Lalani; Heather Yun
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.